Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medi-Caps Ltd is a below average quality company.
The key valuation ratios of Medi-Caps Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medi-Caps Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 4.3% | 2.7% | 2.3% | 1.2% | 1.1% | -13% | 0% | -0.1% | 0.4% | 7.6% | - |
| Value Creation Index ⓘ | -0.7 | -0.8 | -0.8 | -0.9 | -0.9 | -1.9 | NA | -1.0 | -1.0 | -0.5 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 27.4 | 25 | 22.8 | 22.4 | 21.6 | 10.9 | 0 | 0 | 0.1 | 7.2 | 6 |
| Sales YoY Gr. | - | -8.5% | -9.1% | -1.8% | -3.3% | -49.5% | -100% | NA | NA | 7,070% | - |
| Adj EPS ⓘ | 1.2 | 0.9 | 0.9 | 0.5 | 0.5 | -6.7 | 0 | -0.1 | 0.2 | 3.1 | 2 |
| YoY Gr. | - | -18.3% | -1.1% | -51.6% | 6.7% | -1489.6% | NA | NA | NA | 1385.7% | - |
| BVPS (₹) ⓘ | 51.6 | 52.6 | 53.2 | 53.7 | 54.1 | 48 | 48.9 | 49.2 | 49 | 53.3 | 54.2 |
| Adj Net Profit ⓘ | 1.4 | 1.2 | 1.2 | 0.6 | 0.6 | -8.3 | 0 | -0.1 | 0.3 | 3.9 | 2 |
| Cash Flow from Ops. ⓘ | 6.9 | 1.4 | 2.7 | 0.9 | 1.3 | -0.9 | 2.2 | -1 | -2.6 | 3.1 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0.2 | 0.1 | -0.1 | 0 | 0 | 0 | 0 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -13.8% | -19.8% | NA | 7070% | ||||
| Adj EPS ⓘ | 11.7% | 45.4% | NA | 1385.7% | ||||
| BVPSⓘ | 0.4% | -0.3% | 2.9% | 8.8% | ||||
| Share Price | 11.2% | 33.1% | 7.6% | 3.4% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 2.3 | 1.8 | 1.8 | 0.8 | 0.9 | -13.1 | 0 | -0.2 | 0.4 | 6.1 | 3.7 |
| Op. Profit Mgn % ⓘ | 6.8 | 6.5 | 3.5 | 2 | -0 | -83.1 | 0 | 0 | -289.2 | 67.6 | 52.8 |
| Net Profit Mgn % ⓘ | 5.2 | 4.7 | 5.1 | 2.5 | 2.8 | -76.3 | 0 | 0 | 253.7 | 54.3 | 40.3 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Cap Days ⓘ | 221 | 215 | 235 | 209 | 223 | 297 | 0 | 0 | 21,080 | 454 | 785 |
| Cash Conv. Cycle ⓘ | 147 | 161 | 166 | 144 | 148 | 191 | 0 | 0 | 8,062 | 176 | 764 |
Return on Equity has increased versus last 3 years average to 3.60%
Sales growth has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at -13.63%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 2 | -1.2 |
| TTM Sales (₹ Cr.) | 6.1 | 28.8 |
| BVPS (₹.) ⓘ | 54.2 | 99.2 |
| Reserves (₹ Cr.) ⓘ | 55 | 111 |
| P/BV ⓘ | 0.92 | 0.50 |
| PE ⓘ | 25.38 | 0.00 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 40.56 / 63.49 |
| All Time Low / High (₹) | 0.12 / 91.15 |
| Market Cap (₹ Cr.) | 62.2 |
| Equity (₹ Cr.) | 12.5 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 55.9 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27.36 | 25.04 | 22.76 | 22.35 | 21.62 | 10.91 | 0 | 0 | 0.10 | 7.17 |
| Operating Expenses ⓘ | 25.50 | 23.41 | 21.99 | 21.92 | 21.66 | 19.98 | 0 | 0.56 | 0.39 | 2.33 |
| Manufacturing Costs | 5.62 | 5.42 | 4.63 | 4.60 | 4.63 | 3.26 | 0 | 0.01 | 0.01 | 0.12 |
| Material Costs | 12.62 | 10.71 | 9.84 | 9.60 | 9.52 | 9.25 | 0 | 0 | 0 | 0.01 |
| Employee Cost | 4.15 | 4.47 | 4.46 | 4.57 | 4.59 | 5.55 | 0 | 0.45 | 0.23 | 0.50 |
| Other Costs ⓘ | 3.12 | 2.81 | 3.06 | 3.16 | 2.92 | 1.92 | 0 | 0.10 | 0.16 | 1.69 |
| Operating Profit ⓘ | 1.86 | 1.63 | 0.77 | 0.44 | -0.04 | -9.07 | 0 | -0.56 | -0.29 | 4.84 |
| Operating Profit Margin (%) | 6.8% | 6.5% | 3.4% | 2.0% | -0.2% | -83.2% | - | - | -289.0% | 67.6% |
| Other Income ⓘ | 1.21 | 0.46 | 1.13 | 0.68 | 1.14 | 1.12 | 0 | 0.61 | 0.64 | 0.15 |
| Interest ⓘ | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.01 | 0 | 0.01 | 0 | 0 |
| Depreciation ⓘ | 0.32 | 0.33 | 0.37 | 0.34 | 0.35 | 0.36 | 0 | 0.09 | 0.09 | 0.16 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | 2.73 | 1.74 | 1.51 | 0.76 | 0.71 | -8.32 | 0 | -0.06 | 0.26 | 4.83 |
| Tax ⓘ | 0.80 | 0.56 | 0.35 | 0.20 | 0.12 | 0.01 | -0.01 | 0.01 | 0 | 0.94 |
| Profit After Tax | 1.94 | 1.18 | 1.16 | 0.56 | 0.59 | -8.33 | 0.01 | -0.08 | 0.26 | 3.89 |
| PAT Margin (%) | 7.1% | 4.7% | 5.1% | 2.5% | 2.7% | -76.3% | - | - | 253.6% | 54.3% |
| Adjusted EPS (₹) | 1.6 | 1.0 | 0.9 | 0.5 | 0.5 | -6.7 | 0.0 | -0.1 | 0.2 | 3.1 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 64.36 | 65.54 | 66.37 | 66.92 | 67.51 | 59.85 | 60.97 | 61.29 | 61.11 | 66.49 |
| Share Capital ⓘ | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 |
| Reserves ⓘ | 51.89 | 53.07 | 53.90 | 54.45 | 55.04 | 47.38 | 48.50 | 48.82 | 48.64 | 54.02 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 0 | 0 | 0 | 0.17 | 0.12 | 0.06 | 0 | 0 | 0 | 0 |
| Long Term Debt | 0 | 0 | 0 | 0.12 | 0.06 | 0 | 0 | 0 | 0 | 0 |
| Short Term Debt | 0 | 0 | 0 | 0.05 | 0.06 | 0.06 | 0 | 0 | 0 | 0 |
| Trade Payables | 1.22 | 1.87 | 2.24 | 1.47 | 3.08 | 0.42 | 0.03 | 0 | 0 | 0.01 |
| Others Liabilities ⓘ | 3.37 | 3.60 | 3.39 | 3.25 | 3.07 | 1.22 | 1.63 | 0.52 | 0.52 | 1.60 |
| Total Liabilities ⓘ | 68.95 | 71.01 | 72.01 | 71.82 | 73.78 | 61.55 | 62.64 | 61.81 | 61.63 | 68.09 |
Fixed Assets | ||||||||||
| Gross Block | 20.36 | 20.36 | 20.93 | 21.33 | 21.65 | 21.65 | 21.13 | 19.99 | 16.99 | 16.95 |
| Accumulated Depreciation | 16.40 | 16.73 | 17.05 | 17.39 | 17.74 | 18.02 | 17.88 | 17.22 | 14.53 | 14.69 |
| Net Fixed Assetsⓘ | 3.96 | 3.64 | 3.88 | 3.93 | 3.91 | 3.63 | 3.26 | 2.78 | 2.46 | 2.26 |
| CWIP ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investmentsⓘ | 48.25 | 49.56 | 50.37 | 50.89 | 51.75 | 52.15 | 53.31 | 53.68 | 51.98 | 55.11 |
| Inventories | 7.06 | 7.74 | 7.60 | 5.76 | 6.95 | 0.53 | 0.05 | 0 | 0 | 0.03 |
| Trade Receivables | 6.64 | 6.61 | 6.06 | 6.94 | 6.25 | 2.66 | 2.41 | 2.24 | 2.24 | 4.65 |
| Cash Equivalents | 0.90 | 1.03 | 1.97 | 2.04 | 2.13 | 0.75 | 0.73 | 0.79 | 0.04 | 0.05 |
| Others Assetsⓘ | 2.14 | 2.43 | 2.13 | 2.25 | 2.79 | 1.83 | 2.89 | 2.33 | 4.91 | 6 |
| Total Assets ⓘ | 68.95 | 71.01 | 72.01 | 71.82 | 73.78 | 61.55 | 62.64 | 61.81 | 61.63 | 68.09 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 6.88 | 1.44 | 2.70 | 0.86 | 1.33 | -0.92 | 2.24 | -0.95 | -2.60 | 3.09 |
| PBT ⓘ | 2.73 | 1.74 | 1.51 | 0.76 | 0.71 | -8.32 | -0.12 | -0.06 | 0.26 | 4.83 |
| Adjustment ⓘ | 0.32 | 0.33 | 0.37 | 0.34 | 0.35 | 0.94 | 1.57 | 0.58 | -0.28 | 1.65 |
| Changes in Working Capital ⓘ | 4.58 | -0.09 | 1.15 | -0.07 | 0.37 | 6.45 | 0.79 | -1.47 | -2.57 | -2.44 |
| Tax Paid ⓘ | -0.75 | -0.54 | -0.33 | -0.18 | -0.10 | 0 | 0 | 0 | 0 | -0.95 |
| Cash Flow From Investing Activity ⓘ | -6.78 | -1.31 | -1.76 | -0.96 | -1.19 | -0.40 | -2.19 | 1.01 | 1.85 | -3.09 |
| Capex | -0.30 | 0 | -0.61 | -0.40 | -0.33 | 0 | 0.04 | 0.30 | 0.15 | 0.04 |
| Net Investments | -6.50 | -1.31 | -1.15 | -0.56 | -0.86 | -0.41 | -2.23 | 0.71 | 1.70 | -3.13 |
| Others ⓘ | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow From Financing Activityⓘ | 0 | 0 | 0 | 0.17 | -0.05 | -0.06 | -0.06 | 0 | 0 | 0 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | 0 | 0 | 0 | 0.17 | -0.05 | -0.06 | -0.06 | 0 | 0 | 0 |
| Net Cash Flow ⓘ | 0.10 | 0.13 | 0.94 | 0.07 | 0.09 | -1.38 | -0.02 | 0.06 | -0.75 | 0 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 3.05 | 1.82 | 1.75 | 0.85 | 0.88 | -13.08 | 0.01 | -0.12 | 0.42 | 6.09 |
| ROCE (%) | 4.33 | 2.7 | 2.33 | 1.17 | 1.11 | -13.03 | 0 | -0.08 | 0.42 | 7.57 |
| Asset Turnover Ratio | 0.44 | 0.4 | 0.35 | 0.37 | 0.35 | 0.19 | 0 | 0 | 0 | 0.11 |
| PAT to CFO Conversion(x) | 3.55 | 1.22 | 2.33 | 1.54 | 2.25 | N/A | 224 | N/A | -10 | 0.79 | Working Capital Days |
| Receivable Days | 88 | 87 | 91 | 88 | 95 | 126 | 0 | 0 | 8,063 | 175 |
| Inventory Days | 75 | 97 | 111 | 91 | 92 | 106 | 0 | 0 | 0 | 2 |
| Payable Days | 35 | 53 | 76 | 71 | 87 | 69 | 0 | 0 | 0 | 152 |
Medi-Caps incorporated in 1986 is a flagship company of Medi-Caps Group, is one of the largest manufacturer of empty hard gelatin capsules in terms of manufacturing capacity as well as market capitalization in India. Medi-Caps entered the highly competitive market with a team of dedicated professionals, duly supported by competent individuals in every aspect of operation.
Medi-Caps Group’s activities span manufacturing of Hard Gelatin Capsule Shells, Education, Industrial Packaging & related products, Finance, Real Estate and is a renowned name in central India.
At Medi-Caps a philosophy of growth has been consistently upheld with good business practices. Clear focus, excellent infrastructure, a powerful quality policy and a well defined management information system have helped the company to achieve consistent growth. Today they offer printing features that are best in the industry. Medi-Caps has pioneered many advanced features in product development such as “Pearlz Capsules†(Metallic Colored) as well as Python Printing & Li-Fill Caps.
Medi-Caps Limited continuously strives to offer its customers excellent product, technical advice, and a through professional service that makes their product tailor made for their customers both in India as well as abroad.
Their professional goals and corporate personality have blended so well that today Medi-Caps name has become synonymous with the best in the Industry.
Product range of the company includes:
The product product range comprises of six sizes ranging from 00,0el, 0, 1el, 1,2,3,4 in more than 1000 shades, the same is increasing as rapidly as Pharma Industry itself.
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
